SCHEMBL18946019

SCHEMBL18946019

CNC1CCN(c2cc(Cl)cnn2)C1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 17/20 0.51
▸ GLS O94925 3/20 0.48
▸ HRH3 Q9Y5N1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18890300 0.81 GLS (0.52) GLS
SCHEMBL18890299 0.78 HRH4 (0.47) HRH4GLSHRH3
SCHEMBL29544097 0.78 HRH4 (0.47) HRH4GLSHRH3
SCHEMBL18890294 0.77 JAK3 (0.52) GLS
SCHEMBL29544074 0.77 JAK3 (0.52) GLS
SCHEMBL18945892 0.77 JAK3 (0.52) GLS
SCHEMBL19513509 0.77 HRH4 (0.62) HRH4HRH3
SCHEMBL18890288 0.76 GLS (0.57) GLS
SCHEMBL21336454 0.76 GLS (0.57) GLS
SCHEMBL29543830 0.76 GLS (0.57) GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3383871-B1 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2019-09-11 — — EP disclosed
WO-2017093300-A1 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2017-06-08 — — WO disclosed
Send feedback